BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27492604)

  • 1. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
    Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
    Wei C; Zhang X; He S; Liu B; Han H; Sun X
    Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
    Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
    Wang Y; Bao W; Liu Y; Wang S; Xu S; Li X; Li Y; Wu S
    Cell Death Dis; 2018 May; 9(5):447. PubMed ID: 29670086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin downregulates Dicer to promote ovarian cancer metastasis.
    To SKY; Mak ASC; Eva Fung YM; Che CM; Li SS; Deng W; Ru B; Zhang J; Wong AST
    Oncogene; 2017 Oct; 36(43):5927-5938. PubMed ID: 28650464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
    Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation.
    Yang M; Li Q; Yang H; Li Y; Lu L; Wu X; Liu Y; Li W; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li X; Li M
    Biomed Pharmacother; 2024 Apr; 173():116336. PubMed ID: 38412717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
    Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
    Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
    Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.
    Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
    Cancer Lett; 2018 Feb; 415():20-29. PubMed ID: 29199004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
    Yang R; Xu J; Hua X; Tian Z; Xie Q; Li J; Jiang G; Cohen M; Sun H; Huang C
    Oncogene; 2020 Feb; 39(9):1983-1996. PubMed ID: 31772330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
    Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
    Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of S1PR2 inhibition on epithelial ovarian cancer SKOV3 cell proliferation in vitro and in vivo].
    Dai L; Liu YX; Xie L; Di W
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):106-110. PubMed ID: 29534379
    [No Abstract]   [Full Text] [Related]  

  • 18. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2.
    Wu J; Zhao Q; Zhao Y; Zhang X; Tian Y; Guo Z
    Sci Rep; 2021 Mar; 11(1):6993. PubMed ID: 33772068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer.
    Fan Y; Ma X; Li H; Gao Y; Huang Q; Zhang Y; Bao X; Du Q; Luo G; Liu K; Meng Q; Zhao C; Zhang X
    Int J Cancer; 2018 Feb; 142(3):547-560. PubMed ID: 28921581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.